31 August 2016 - Over the past few days media reports have claimed NPS MedicineWise is ‘selling access to our data program’ and ‘taking drug company cash to educate GPs’.

The CEO of the National Prescribing Service (NPS) wants set the record straight and clarify this situation directly.

Key points

• Claims that the NPS is selling data and ‘selling out’ to big pharma are misleading and simply do not reflect the real situation.
• All decisions the NPS makes about working with different customers carefully consider our independence, integrity and longstanding trust with health professionals and the Australian community and the NPS will not compromise this.
• Delivering programs of the highest integrity, based on evidence and supporting health professionals to optimise health outcomes is the NPS' continuing priority.
• MedicineInsight is subject to rigorous and ethical data access and governance and is only used for public good.
• The landscape is shifting and new models of support for high-quality health professional education are emerging in response to community concerns.

Read NPS Statement